Xiaomeng Hao

484 total citations
17 papers, 372 citations indexed

About

Xiaomeng Hao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaomeng Hao has authored 17 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Xiaomeng Hao's work include Breast Cancer Treatment Studies (4 papers), Cancer-related Molecular Pathways (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Xiaomeng Hao is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Cancer-related Molecular Pathways (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Xiaomeng Hao collaborates with scholars based in China, United Kingdom and Sweden. Xiaomeng Hao's co-authors include Sheng Zhang, Jin Zhang, Xiaobei Zhang, Yi Ma, Guofang Hou, Sheng Zhang, Jingjing Liu, Yan Liu, Jin Zhang and Pei Wang and has published in prestigious journals such as Scientific Reports, Breast Cancer Research and Treatment and Cell Cycle.

In The Last Decade

Xiaomeng Hao

17 papers receiving 368 citations

Peers

Xiaomeng Hao

ONCOL

GENET

PRM

Juan Antonio Barrera Spain

Mohammad Daremipouran United States

Jacqueline E. Mann United States

Xiangshan Yang China

Sourat Darabi United States

Motohiko Tanino Japan

Lurdes Torres Portugal

Hiroshi Nishimiya Japan

Elena Piñeiro-Yáñez Spain

Chelsea Mullins United States

Juan Antonio Barrera Spain

Xiaomeng Hao

151 ×0.7

132 ×0.8

161 ×1.0

ONCOL

25 ×0.5

GENET

106 ×2.2

PRM

Citations per year, relative to Xiaomeng Hao Xiaomeng Hao (= 1×) peers Juan Antonio Barrera

Countries citing papers authored by Xiaomeng Hao

Since Specialization

Citations

This map shows the geographic impact of Xiaomeng Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomeng Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomeng Hao more than expected).

Fields of papers citing papers by Xiaomeng Hao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaomeng Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomeng Hao. The network helps show where Xiaomeng Hao may publish in the future.

Co-authorship network of co-authors of Xiaomeng Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomeng Hao. A scholar is included among the top collaborators of Xiaomeng Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomeng Hao. Xiaomeng Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ma, Tao, et al.. (2025). Predictive markers of rapid disease progression and chemotherapy resistance in triple-negative breast cancer patients following postoperative adjuvant therapy. Scientific Reports. 15(1). 386–386. 1 indexed citations

Zhang, Lijuan, et al.. (2023). MEL regulates miR-21 and let-7b through the STAT3 cascade in the follicular granulosa cells of Tibetan sheep. Theriogenology. 205. 114–129. 2 indexed citations

Liu, Lei, et al.. (2021). Correlation between family history and characteristics of breast cancer. Scientific Reports. 11(1). 6360–6360. 38 indexed citations

Hao, Xiaomeng, Yufan Qiu, Lixia Cao, et al.. (2021). Over-Expression of Centromere Protein U Participates in the Malignant Neoplastic Progression of Breast Cancer. Frontiers in Oncology. 11. 615427–615427. 5 indexed citations

Wang, Xueli, Mei Qi, Jing Zhang, et al.. (2019). Differential response to neoadjuvant hormonal therapy in prostate cancer: Predictive morphological parameters and molecular markers. The Prostate. 79(7). 709–719. 20 indexed citations

Hao, Xiaomeng & Ping Lei. (2015). A Brief Study on Green Technology Innovation of China’s CoalEnterprises. 8(1). 287–290. 1 indexed citations

Su, Wei, Sheng Zhang, Chunyan Li, Xiaomeng Hao, & Jin Zhang. (2015). [Efficacy and safety analysis of paclitaxel liposome and docetaxel for the neoadjuvant chemotherapy of breast cancer].. PubMed. 37(5). 379–82. 4 indexed citations

Liu, Yan, Xiaobei Zhang, Jingjing Liu, et al.. (2014). [Prognostic significance of Ki-67 expression before and after neoadjuvant chemotherapy in different biological breast cancer phenotypes].. PubMed. 36(9). 671–6. 3 indexed citations

Li, Chunyan, Xiaomeng Hao, Sheng Zhang, et al.. (2014). Multi-gene fluorescence in situ hybridization to detect cell cycle gene copy number aberrations in young breast cancer patients. Cell Cycle. 13(8). 1299–1305. 11 indexed citations

10.

Sun, Bei, et al.. (2013). Clinicopathologic characteristics and prognostic analysis of luminal B breast cancer patients with diabetes. 40(17). 1042–1046. 1 indexed citations

11.

Hou, Guofang, Sheng Zhang, Xiaobei Zhang, et al.. (2013). Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes. Breast Cancer Research and Treatment. 137(3). 807–816. 74 indexed citations

12.

Zhang, Sheng, et al.. (2013). Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer. Tumor Biology. 35(3). 2035–2045. 29 indexed citations

13.

Liu, Jingjing, et al.. (2013). Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients.. PubMed. 25(1). 46–54. 85 indexed citations

14.

Liu, Jing‐Jing, Sheng Zhang, Xiaomeng Hao, et al.. (2011). Breast-conserving therapy versus modified radical mastectomy: Socioeconomic status determines who receives what—Results from case–control study in Tianjin, China. Cancer Epidemiology. 36(1). 89–93. 23 indexed citations

15.

Ma, Yi, et al.. (2011). The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells. Breast Cancer Research and Treatment. 133(2). 473–485. 72 indexed citations

16.

Xu, Liang, Xiaomeng Hao, Min Zhang, & Jin Zhang. (2010). Clinical Trial on the Efficacy of Zoledronic Acid in Preventing Bone Loss Induced by Aromatase Inhibitor in Breast Cancer. Clinical Oncology and Cancer Research. 37(7). 392–394. 1 indexed citations

17.

Chen, Sumin, et al.. (1997). A gene encoding Era-binding protein exists in E. coli genome. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 24(6). 559–561. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact